<DOC>
	<DOCNO>NCT01404793</DOCNO>
	<brief_summary>Standard anesthetic management liver transplantation patient include general anesthetic use multiple drug , include neuromuscular relaxant rocuronium . Pharmacokinetic modelling agent poorly describe liver transplantation , impact appropriate dose agent within population plasma concentration vary fluid shift hepatic drug metabolism various phase liver transplantation . Plasma drug drug metabolite concentration measure use technique solid phase micro-extraction ( SPME ) . Measuring correlating level rocuronium liver metabolite degree post transplantation hepatic dysfunction may serve simple cost-effective marker aid diagnosis , identify risk hepatic dysfunction potentially grade severity</brief_summary>
	<brief_title>SPME For Metabolomics And Concomitant Measurements Of Rocuronium Bromide Levels In Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>First time liver transplant recipients 18 year age Elective cadaveric live donor liver transplant patient recruit All patient 18 year age Unable give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Liver Transplantation</keyword>
	<keyword>Solid Phase Micro Extraction</keyword>
	<keyword>Rocuronium</keyword>
	<keyword>Metabolomics</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Clinical Marker</keyword>
</DOC>